Brief: Angion Announces Process To Explore Strategic Alternatives For Enhancing And Preserving Shareholder Value
25/07/2022 22:04
July 25 (Reuters) - Angion Biomedica Corp ANGN.O :
* ANGION ANNOUNCES PROCESS TO EXPLORE STRATEGIC ALTERNATIVES
FOR
ENHANCING AND PRESERVING SHAREHOLDER VALUE
* ANGION BIOMEDICA CORP - COMMENCED A PROCESS TO EXPLORE AND
EVALUATE STRATEGIC OPTIONS TO ENHANCE AND PRESERVE SHAREHOLDER
VALUE.
* ANGION BIOMEDICA - APPROVED ENGAGEMENT OF OPPENHEIMER &
CO.,
INC. AS COMPANY'S EXCLUSIVE FINANCIAL ADVISOR TO ASSIST IN
STRATEGIC ALTERNATIVES PROCESS
Source text for Eikon: ID:nGNX8fchF6
Further company coverage: ANGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elicio Therapeutics
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Elicio Therapeutics Q2 net loss narrows as R&D expenses fall
Elicio Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex
Elicio shares slide after pancreatic cancer vaccine falls short in mid-stage study (updated)